Regarding the detection solutions, immunoassay assessments with the screening of selected SCs are commercially obtainable but want confirmation by LC-MS/MS and have become quickly obsolete, as revealed by Franz and Other individuals [sixty]. The fast enhancement of new SCs is actually a limitation even for targeted mass spectrometry screening metho